Literature DB >> 7599061

New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.

R J Mairs, M R Zalutsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7599061      PMCID： PMC2034123          DOI： 10.1038/bjc.1995.312

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  3 in total

Review 1.  Neuropharmacology of emesis induced by anti-cancer therapy.

Authors:  P L Andrews; W G Rapeport; G J Sanger
Journal:  Trends Pharmacol Sci       Date:  1988-09       Impact factor: 14.819

2.  No-carrier-added synthesis of meta-[131I]iodobenzylguanidine.

Authors:  G Vaidyanathan; M R Zalutsky
Journal:  Appl Radiat Isot       Date:  1993-03       Impact factor: 1.513

3.  Delayed chemotherapy-induced nausea is augmented by high levels of endogenous noradrenaline.

Authors:  M Fredrikson; T J Hursti; G Steineck; C J Fürst; S Börjesson; C Peterson
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640
  3 in total
  1 in total

1.  Comparison of iodine-123 metaiodobenzylguanidine (MIBG) scan and [18F]fluorodeoxyglucose positron emission tomography to evaluate response after iodine-131 MIBG therapy for relapsed neuroblastoma.

Authors:  Denah R Taggart; Myo M Han; Alekist Quach; Susan Groshen; Wei Ye; Judith G Villablanca; Hollie A Jackson; Carina Mari Aparici; David Carlson; John Maris; Randall Hawkins; Katherine K Matthay
Journal:  J Clin Oncol       Date:  2009-10-05       Impact factor: 44.544
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.